Formulation of LDL targeted nanostructured lipid carriers loaded with paclitaxel: A detailed study of preparation, freeze drying condition, and in vitro cytotoxicity

Journal of Nanomaterials

Volumn 2012, Issue , 2012, Pages

  Emami, Jaber ^a   Rezazadeh, Mahboubeh ^a   Varshosaz, Jaleh ^a   Tabbakhian, Majid ^a   Aslani, Abolfazl ^a  

^a ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

ACID CONTENT; CANCER CELLS; CELL LINES; CRYOPROTECTANTS; DRUG CONTENT; DRUG LOADING; DRUG RELEASE; EMULSIFICATION-DIFFUSION METHODS; ENDOCYTIC PATHWAYS; ENTRAPMENT EFFICIENCY; FREEZE DRYING; IN-VITRO; NANOSTRUCTURED LIPID CARRIERS; PACLITAXEL; RELEASE PROPERTY; TAGUCHI DESIGN; WEIGHT RATIOS;

CELL CULTURE; EMULSIFICATION; UNSATURATED FATTY ACIDS; ZETA POTENTIAL;

OLEIC ACID;

EID: 84872148890     PISSN: 16874110     EISSN: 16874129     Source Type: Journal    
DOI: 10.1155/2012/358782     Document Type: Article

References (37)

1. Alani A. W. G., Bae Y., Rao D. A., Kwon G. S., Polymeric micelles for the pH-dependent controlled, continuous low dose release of paclitaxel. Biomaterials 2010 31 7 1765 1772 2-s2.0-73249127797 10.1016/j.biomaterials.2009. 11.038
2. Kim J. H., Kim Y. S., Kim S., Park J. H., Kim K., Choi K., Chung H., Jeong S. Y., Park R. W., Kim I. S., Kwon I. C., Hydrophobically modified glycol chitosan nanoparticles as carriers for paclitaxel. Journal of Controlled Release 2006 111 1-2 228 234 2-s2.0-33344466821 10.1016/j.jconrel.2005.12.013 (Pubitemid 43290012)
3. Nornoo A. O., Osborne D. W., Chow D. S. L., Cremophor-free intravenous microemulsions for paclitaxel. I: formulation, cytotoxicity and hemolysis. International Journal of Pharmaceutics 2008 349 1-2 108 116 2-s2.0-37349120679 10.1016/j.ijpharm.2007.07.042 (Pubitemid 350299695)
4. Fetterly G. J., Straubinger R. M., Pharmacokinetics of paclitaxel-containing liposomes in rats. AAPS PharmSci 2003 5 4 90 100 2-s2.0-0346040088 10.1208/ps050432 (Pubitemid 38097477)
5. Hawkins M. J., Soon-Shiong P., Desai N., Protein nanoparticles as drug carriers in clinical medicine. Advanced Drug Delivery Reviews 2008 60 8 876 885 2-s2.0-42649132499 10.1016/j.addr.2007.08.044
6. Danhier F., Lecouturier N., Vroman B., Jérôme C., Marchand-Brynaert J., Feron O., Préat V., Paclitaxel-loaded PEGylated PLGA-based nanoparticles: in vitro and in vivo evaluation. Journal of Controlled Release 2009 133 1 11 17 2-s2.0-57049140409 10.1016/j.jconrel.2008.09.086
7. Lacoeuille F., Hindre F., Moal F., Roux J., Passirani C., Couturier O., Cales P., Le Jeune J. J., Lamprecht A., Benoit J. P., In vivo evaluation of lipid nanocapsules as a promising colloidal carrier for paclitaxel. International Journal of Pharmaceutics 2007 344 1-2 143 149 2-s2.0-34648831611 10.1016/j.ijpharm.2007.06.014 (Pubitemid 47464828)
8. Sharma U. S., Balasubbamanian S. V., Straubinger R. M., Pharmaceutical and physical properties of paclitaxel (Taxol) complexes with cyclodextrins. Journal of Pharmaceutical Sciences 1995 84 10 1223 1230 2-s2.0-0028838372 10.1002/jps.2600841015
9. Elsadek B., Graeser R., Esser N., Schäfer-Obodozie C., Ajaj K. A., Unger C., Warnecke A., Saleem T., El-Melegy N., Madkor H., Kratz F., Development of a novel prodrug of paclitaxel that is cleaved by prostate-specific antigen: an in vitro and in vivo evaluation study. European Journal of Cancer 2010 46 18 3434 3444 2-s2.0-78649634752 10.1016/j.ejca.2010.08.018
10. Zhang X., Jackson J. K., Burt H. M., Development of amphiphilic diblock copolymers as micellar carriers of taxol. International Journal of Pharmaceutics 1996 132 1-2 195 206 2-s2.0-0029980834 10.1016/0378-5173(95)04386-1 (Pubitemid 26158719)
11. Kim S. C., Kim D. W., Shim Y. H., Bang J. S., Oh H. S., Kim S. W., Seo M. H., In vivo evaluation of polymeric micellar paclitaxel formulation: toxicity and efficacy. Journal of Controlled Release 2001 72 1-3 191 202 2-s2.0-0035858296 10.1016/S0168-3659(01)00275-9 (Pubitemid 32522357)
12. Hamaguchi T., Matsumura Y., Suzuki M., Shimizu K., Goda R., Nakamura I., Nakatomi I., Yokoyama M., Kataoka K., Kakizoe T., NK105, a paclitaxel- incorporating micellar nanoparticle formulation, can extend in vivo antitumour activity and reduce the neurotoxicity of paclitaxel. British Journal of Cancer 2005 92 7 1240 1246 2-s2.0-20944450473 10.1038/sj.bjc.6602479 (Pubitemid 40604398)
13. Zhang C., Qineng P., Zhang H., Self-assembly and characterization of paclitaxel-loaded N-octyl-O-sulfate chitosan micellar system. Colloids and Surfaces B 2004 39 1-2 69 75 2-s2.0-8144225129 10.1016/j.colsurfb.2004.09.002 (Pubitemid 39473356)
14. Hu F. Q., Ren G. F., Yuan H., Du Y. Z., Zeng S., Shell cross-linked stearic acid grafted chitosan oligosaccharide self-aggregated micelles for controlled release of paclitaxel. Colloids and Surfaces B 2006 50 2 97 103 2-s2.0-33745346800 10.1016/j.colsurfb.2006.04.009 (Pubitemid 43946659)
15. Huo M., Zhang Y., Zhou J., Zou A., Li J., Formation, microstructure, biodistribution and absence of toxicity of polymeric micelles formed by N-octyl-N,O-carboxymethyl chitosan. Carbohydrate Polymers 2011 83 4 1959 1969 2-s2.0-78650523106 10.1016/j.carbpol.2010.10.073
16. Müller R. H., Mäder K., Gohla S., Solid lipid nanoparticles (SLN) for controlled drug delivery-a review of the state of the art. European Journal of Pharmaceutics and Biopharmaceutics 2000 50 1 161 177 2-s2.0-0038032150 10.1016/S0939-6411(00)00087-4 (Pubitemid 30326695)
17. Müller R. H., Radtke M., Wissing S. A., Nanostructured lipid matrices for improved microencapsulation of drugs. International Journal of Pharmaceutics 2002 242 1-2 121 128 2-s2.0-0037151496 10.1016/S0378-5173(02) 00180-1
18. Pinheiro K. V., Hungria V. T. M., Ficker E. S., Valduga C. J., Mesquita C. H., Maranhão R. C., Plasma kinetics of a cholesterol-rich microemulsion (LDE) in patients with Hodgkin's and non-Hodgkin's lymphoma and a preliminary study on the toxicity of etoposide associated with LDE. Cancer Chemotherapy and Pharmacology 2006 57 5 624 630 2-s2.0-32544437171 10.1007/s00280-005-0090-8 (Pubitemid 43237847)
19. Maranh R. C., Graziani S. R., Yamaguchi N., Association of carmustine with a lipid emulsion: in vitro, in vivo and preliminary studies in cancer patients. Cancer Chemotherapy and Pharmacology 2002 49 487 498 (Pubitemid 34671285)
20. Valduga C. J., Fernandes D. C., Lo Prete A. C., Azevedo C. H. M., Rodrigues D. G., Maranhão R. C., Use of a cholesterol-rich microemulsion that binds to low-density lipoproteins receptors as vehicle for etoposide. Journal of Pharmacy and Pharmacology 2003 55 12 1615 1622 2-s2.0-0347989311 10.1211/0022357022232 (Pubitemid 38054391)
21. Rodrigues D. G., Maria D. A., Fernandes D. C., Valduga C. J., Couto R. D., Ibañez O. C. M., Maranhão R. C., Improvement of paclitaxel therapeutic index by derivatization and association to a cholesterol-rich microemulsion: in vitro and in vivo studies. Cancer Chemotherapy and Pharmacology 2005 55 6 565 576 2-s2.0-18744406323 10.1007/s00280-004-0930-y (Pubitemid 40674632)
22. Nishiyama N., Kataoka K., Current state, achievements, and future prospects of polymeric micelles as nanocarriers for drug and gene delivery. Pharmacology and Therapeutics 2006 112 3 630 648 2-s2.0-33750136313 10.1016/j.pharmthera.2006.05.006 (Pubitemid 44592613)
23. Serpe L., Catalano M. G., Cavalli R., Ugazio E., Bosco O., Canaparo R., Muntoni E., Frairia R., Gasco M. R., Eandi M., Zara G. P., Cytotoxicity of anticancer drugs incorporated in solid lipid nanoparticles on HT-29 colorectal cancer cell line. European Journal of Pharmaceutics and Biopharmaceutics 2004 58 3 673 680 2-s2.0-4644268591 10.1016/j.ejpb.2004.03.026 (Pubitemid 39297116)
24. Zhang X. G., Miao J., Dai Y. Q., Du Y. Z., Yuan H., Hu F. Q., Reversal activity of nanostructured lipid carriers loading cytotoxic drug in multi-drug resistant cancer cells. International Journal of Pharmaceutics 2008 361 1-2 239 244 2-s2.0-47949106574 10.1016/j.ijpharm.2008.06.002
25. Lee M. K., Lim S. J., Kim C. K., Preparation, characterization and in vitro cytotoxicity of paclitaxel-loaded sterically stabilized solid lipid nanoparticles. Biomaterials 2007 28 12 2137 2146 2-s2.0-33846677328 10.1016/j.biomaterials.2007.01.014 (Pubitemid 46198929)
26. Li R., Eun J. S., Lee M. K., Pharmacokinetics and biodistribution of paclitaxel loaded in pegylated solid lipid nanoparticles after intravenous administration. Archives of Pharmacal Research 2011 34 2 331 337 2-s2.0-79953302226 10.1007/s12272-011-0220-2
27. Yuan H., Miao J., Du Y. Z., You J., Hu F. Q., Zeng S., Cellular uptake of solid lipid nanoparticles and cytotoxicity of encapsulated paclitaxel in A549 cancer cells. International Journal of Pharmaceutics 2008 348 1-2 137 145 2-s2.0-37249078585 10.1016/j.ijpharm.2007.07.012 (Pubitemid 350266242)
28. Liu D., Liu Z., Wang L., Zhang C., Zhang N., Nanostructured lipid carriers as novel carrier for parenteral delivery of docetaxel. Colloids and Surfaces B 2011 85 2 262 269 2-s2.0-79955643481 10.1016/j.colsurfb.2011.02.038
29. Hu F. Q., Zhang Y., Du Y. Z., Yuan H., Nimodipine loaded lipid nanospheres prepared by solvent diffusion method in a drug saturated aqueous system. International Journal of Pharmaceutics 2008 348 1-2 146 152 2-s2.0-37249041394 10.1016/j.ijpharm.2007.07.025 (Pubitemid 350266243)
30. Hu F. Q., Jiang S. P., Du Y. Z., Yuan H., Ye Y. Q., Zeng S., Preparation and characterization of stearic acid nanostructured lipid carriers by solvent diffusion method in an aqueous system. Colloids and Surfaces B 2005 45 3-4 167 173 2-s2.0-26244444984 10.1016/j.colsurfb.2005.08.005 (Pubitemid 41415646)
31. Müller R. H., Radtke M., Wissing S. A., Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) in cosmetic and dermatological preparations. Advanced Drug Delivery Reviews 2002 54 S131 S155 2-s2.0-2242472082 10.1016/S0169-409X(02)00118-7 (Pubitemid 35379959)
32. Varshosaz J., Eskandari S., Tabbakhian M., Freeze-drying of nanostructure lipid carriers by different carbohydrate polymers used as cryoprotectants. Carbohydrate Polymer 2012 88 1157 1163
33. Freitas C., Müller R. H., Effect of light and temperature on zeta potential and physical stability in solid lipid nanoparticle (SLN) dispersions. International Journal of Pharmaceutics 1998 168 2 221 229 2-s2.0-0032526787 10.1016/S0378-5173(98)00092-1 (Pubitemid 28349963)
34. Lim S. J., Kim C. K., Formulation parameters determining the physicochemical characteristics of solid lipid nanoparticles loaded with all-trans retinoic acid. International Journal of Pharmaceutics 2002 243 1-2 135 146 2-s2.0-0037190052 10.1016/S0378-5173(02)00269-7
35. Mosqueira V. C. F., Legrand P., Morgat J. L., Vert M., Mysiakine E., Gref R., Devissaguet J. P., Barratt G., Biodistribution of long-circulating PEG-grafted nanocapsules in mice: effects of PEG chain length and density. Pharmaceutical Research 2001 18 10 1411 1419 2-s2.0-0034781649 10.1023/A:1012248721523 (Pubitemid 32977246)
36. Souto E. B., Wissing S. A., Barbosa C. M., Müller R. H., Development of a controlled release formulation based on SLN and NLC for topical clotrimazole delivery. International Journal of Pharmaceutics 2004 278 1 71 77 2-s2.0-2442712381 10.1016/j.ijpharm.2004.02.032 (Pubitemid 38670438)
37. Saez A., Guzmán M., Molpeceres J., Aberturas M. R., Freeze-drying of polycaprolactone and poly(D,L-lactic-glycolic) nanoparticles induce minor particle size changes affecting the oral pharmacokinetics of loaded drugs. European Journal of Pharmaceutics and Biopharmaceutics 2000 50 3 379 387 2-s2.0-0033790335 10.1016/S0939-6411(00)00125-9